SCHEMBL13626683

SCHEMBL13626683

CCN(c1cc(OC)c(OC)cc1[C@@H]1CCc2cc(O)ccc2C1)C(C)c1ccc(OCCN(C)C(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.42
ESR2 Q92731 1/20 0.42
DRD2 P14416 8/20 0.35
DRD3 P35462 7/20 0.35
CYP26A1 O43174 1/20 0.34
RAB9A P51151 1/20 0.34
DRD1 P21728 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
DRD4 P21917 4/20 0.33
MIF P14174 1/20 0.33
ACHE P22303 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HTR1A P08908 1/20 0.32
ADRB2 P07550 1/20 0.32
CYP2D6 P10635 1/20 0.32
CASP1 P29466 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626666 0.94 ESR1 (0.42) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626667 0.92 ESR1 (0.42) ESR1ESR2DRD2DRD3RAB9A
SCHEMBL13626682 0.92 ESR1 (0.40) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626699 0.91 ESR1 (0.40) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626681 0.91 ESR1 (0.40) ESR1ESR2DRD2DRD3RAB9A
SCHEMBL13626678 0.88 ESR1 (0.40) ESR1ESR2DRD2CYP26A1RAB9A
SCHEMBL13626695 0.88 ESR1 (0.38) ESR1ESR2DRD2DRD3RAB9A
SCHEMBL13626697 0.88 ESR1 (0.39) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL229873 0.88 ESR1 (0.57) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL229055 0.88 ESR1 (0.57) ESR1ESR2DRD2DRD3CYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed